5,8-Dihydro-1,7-Naphthyridine Derivatives As Glp-1 Agonists For The Treatment Of Diabetes
Patent No. EP4496797 (titled "5,8-Dihydro-1,7-Naphthyridine Derivatives As Glp-1 Agonists For The Treatment Of Diabetes") was filed by Gasherbrum BIO on Mar 20, 2023. The application was issued on Jan 29, 2025.
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4496797
- Application Number
- EP23718162A
- Filing Date
- Mar 20, 2023
- Status
- Request For Examination Was Made
- Dec 26, 2024
- Publication Date
- Jan 29, 2025
- External Links
- Slate, Register , Google Patents